Coverart for item
The Resource Comprehensive Accounts of Pharmaceutical Research and Development : From Discovery to Late-Stage Process Development, Volume 2, Ahmed F. Abdel-Magid, editor, Jaan A. Pesti, editor, Rajappa Vaidyanathan, editor ; sponsored by the ACS Division of Organic Chemistry

Comprehensive Accounts of Pharmaceutical Research and Development : From Discovery to Late-Stage Process Development, Volume 2, Ahmed F. Abdel-Magid, editor, Jaan A. Pesti, editor, Rajappa Vaidyanathan, editor ; sponsored by the ACS Division of Organic Chemistry

Label
Comprehensive Accounts of Pharmaceutical Research and Development : From Discovery to Late-Stage Process Development, Volume 2
Title
Comprehensive Accounts of Pharmaceutical Research and Development
Title remainder
From Discovery to Late-Stage Process Development
Title number
Volume 2
Statement of responsibility
Ahmed F. Abdel-Magid, editor, Jaan A. Pesti, editor, Rajappa Vaidyanathan, editor ; sponsored by the ACS Division of Organic Chemistry
Contributor
Editor
Sponsoring body
Subject
Language
eng
Member of
Cataloging source
CASSC
Dewey number
615.1/9
Illustrations
illustrations
Index
index present
LC call number
RS403
LC item number
.C66 2016 v.2
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
QV 744
NLM item number
C737 2016 vol. 2
http://library.link/vocab/relatedWorkOrContributorDate
  • 1947-
  • 1954-
http://library.link/vocab/relatedWorkOrContributorName
  • Abdel-Magid, Ahmed F.
  • Pesti, Jaan A.
  • Vaidyanathan, Rajappa
  • American Chemical Society
Series statement
ACS symposium series,
Series volume
1240
http://library.link/vocab/subjectName
  • Pharmaceutical chemistry
  • Drugs
  • Drug development
  • Drugs
  • Pharmaceutical industry
  • Chemical inhibitors
  • Enzyme inhibitors
  • Drug antagonism
  • Glucocorticoids
  • Chemistry, Pharmaceutical
  • Drug Design
  • Drug Industry
  • Drug Evaluation
  • Drug Industry
  • Ubiquitins
  • Enzyme Inhibitors
  • Drug Antagonism
  • Glucocorticoids
  • MEDICAL / Pharmacology
  • MEDICAL / Research
  • Drug development
  • Drugs
  • Drugs
  • Pharmaceutical chemistry
  • Pharmaceutical industry
Label
Comprehensive Accounts of Pharmaceutical Research and Development : From Discovery to Late-Stage Process Development, Volume 2, Ahmed F. Abdel-Magid, editor, Jaan A. Pesti, editor, Rajappa Vaidyanathan, editor ; sponsored by the ACS Division of Organic Chemistry
Instantiates
Publication
Note
Distributed in print by Oxford University Press
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type MARC source
rdacontent
Contents
  • Design and Enabling Development of Hydroxyethylamine-Derived BACE1 Inhibitor
  • Tedrow, Jason S., Process Development, Amgen Inc, One Amgen Center Drive, Thousand Oaks, California 91320, United States; Zhong, Wenge, Discovery Research, Amgen Asia R&D Center, 99 Haike Road, 4th Floor, Building 6, Shanghai 201210, P. R. China /
  • Identification and Optimization of a Series of Non-Steroidal Trifluoromethylcarbinol Glucocorticoid Receptor Agonists
  • Harcken, Christian, Department of Immunology and Respiratory Discovery Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06778, United States; Razavi, Hossein, Department of Small Molecule Discovery Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06778, United States /
  • Development of an Asymmetric Route for Large-Scale Synthesis of a Glucocorticoid Agonist
  • Reeves, Jonathan T.; Fandrick, Daniel R.; Song, Jinhua J.; Tan, Zhulin; Kim, Soojin; Yang, Bing-Shiou; Yee, Nathan K.; Senanayake, Chris H. /
  • Synthesis of a Potent NAE Inhibitor: Pevonedistat
  • The Medicinal Chemistry and Commercial Manufacturing Behind the Discovery and Development of the Hedgehog Inhibitor Vismodegib
  • Angelaud, Remy, Small Molecule Process Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States; Sutherlin, Daniel P., Discovery Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States; Reynolds, Mark, Small Molecule Process Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States; Savage, Scott, Small Molecule Process Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States; Stumpf, Andreas, Small Molecule Process Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States /
  • Discovery and Process Development of Class I PI3K and Class I PI3K/mTOR Inhibitors GDC-0941 and GDC-0980
  • Babu, Srinivasan, Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Gosselin, Francis, Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Humphries, Theresa, Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Olivero, Alan, Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Sutherlin, Daniel, Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Tian, Qingping, Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States /
  • The Development and Manufacture of Azacitidine, Decitabine, and Cladribine: Stereoselective Ribonucleoside Drug Synthesis Using the Vorbrüggen Glycosylation
  • Co, Erick W.; Henschke, Julian P. /
  • Editors' Biographies /
  • Mizutani, Hirotaki; Langston, Steven; Vyskocil, Stepan /
  • Process Development and GMP Production of a Potent NEDD8-Activating Enzyme (NAE) Inhibitor: Pevonedistat
  • Armitage, Ian; McCarron, Ashley; Zhu, Lei /
  • The Discovery and Synthesis of the CGRP Receptor Antagonist MK-3207
  • Bell, Ian M., Department of Discovery Chemistry, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States; Bulger, Paul G., Department of Process Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States; McLaughlin, Mark, Department of Process Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States /
Control code
970356547
Dimensions
unknown
Extent
1 online resource (347 pages)
File format
unknown
Form of item
online
Isbn
9780841231917
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Other physical details
illustrations.
Quality assurance targets
not applicable
Reformatting quality
unknown
Specific material designation
remote
System control number
(OCoLC)970356547
Label
Comprehensive Accounts of Pharmaceutical Research and Development : From Discovery to Late-Stage Process Development, Volume 2, Ahmed F. Abdel-Magid, editor, Jaan A. Pesti, editor, Rajappa Vaidyanathan, editor ; sponsored by the ACS Division of Organic Chemistry
Publication
Note
Distributed in print by Oxford University Press
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type MARC source
rdacontent
Contents
  • Design and Enabling Development of Hydroxyethylamine-Derived BACE1 Inhibitor
  • Tedrow, Jason S., Process Development, Amgen Inc, One Amgen Center Drive, Thousand Oaks, California 91320, United States; Zhong, Wenge, Discovery Research, Amgen Asia R&D Center, 99 Haike Road, 4th Floor, Building 6, Shanghai 201210, P. R. China /
  • Identification and Optimization of a Series of Non-Steroidal Trifluoromethylcarbinol Glucocorticoid Receptor Agonists
  • Harcken, Christian, Department of Immunology and Respiratory Discovery Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06778, United States; Razavi, Hossein, Department of Small Molecule Discovery Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06778, United States /
  • Development of an Asymmetric Route for Large-Scale Synthesis of a Glucocorticoid Agonist
  • Reeves, Jonathan T.; Fandrick, Daniel R.; Song, Jinhua J.; Tan, Zhulin; Kim, Soojin; Yang, Bing-Shiou; Yee, Nathan K.; Senanayake, Chris H. /
  • Synthesis of a Potent NAE Inhibitor: Pevonedistat
  • The Medicinal Chemistry and Commercial Manufacturing Behind the Discovery and Development of the Hedgehog Inhibitor Vismodegib
  • Angelaud, Remy, Small Molecule Process Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States; Sutherlin, Daniel P., Discovery Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States; Reynolds, Mark, Small Molecule Process Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States; Savage, Scott, Small Molecule Process Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States; Stumpf, Andreas, Small Molecule Process Chemistry, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, California 94080, United States /
  • Discovery and Process Development of Class I PI3K and Class I PI3K/mTOR Inhibitors GDC-0941 and GDC-0980
  • Babu, Srinivasan, Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Gosselin, Francis, Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Humphries, Theresa, Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Olivero, Alan, Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Sutherlin, Daniel, Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States; Tian, Qingping, Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States /
  • The Development and Manufacture of Azacitidine, Decitabine, and Cladribine: Stereoselective Ribonucleoside Drug Synthesis Using the Vorbrüggen Glycosylation
  • Co, Erick W.; Henschke, Julian P. /
  • Editors' Biographies /
  • Mizutani, Hirotaki; Langston, Steven; Vyskocil, Stepan /
  • Process Development and GMP Production of a Potent NEDD8-Activating Enzyme (NAE) Inhibitor: Pevonedistat
  • Armitage, Ian; McCarron, Ashley; Zhu, Lei /
  • The Discovery and Synthesis of the CGRP Receptor Antagonist MK-3207
  • Bell, Ian M., Department of Discovery Chemistry, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States; Bulger, Paul G., Department of Process Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States; McLaughlin, Mark, Department of Process Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States /
Control code
970356547
Dimensions
unknown
Extent
1 online resource (347 pages)
File format
unknown
Form of item
online
Isbn
9780841231917
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Other physical details
illustrations.
Quality assurance targets
not applicable
Reformatting quality
unknown
Specific material designation
remote
System control number
(OCoLC)970356547

Library Locations

    • Curtis Laws Wilson LibraryBorrow it
      400 West 14th Street, Rolla, MO, 65409, US
      37.955220 -91.772210
Processing Feedback ...